Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Manipulation of Cell-Type Selective Antibody Internalization by a Guide-Effector Bispecific Design.

Lee NK, Su Y, Bidlingmaier S, Liu B.

Mol Cancer Ther. 2019 Jun;18(6):1092-1103. doi: 10.1158/1535-7163.MCT-18-1313. Epub 2019 Apr 8.

PMID:
30962321
2.

Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer.

Su Y, Liu Y, Behrens CR, Bidlingmaier S, Lee NK, Aggarwal R, Sherbenou DW, Burlingame AL, Hann BC, Simko JP, Premasekharan G, Paris PL, Shuman MA, Seo Y, Small EJ, Liu B.

JCI Insight. 2018 Sep 6;3(17). pii: 121497. doi: 10.1172/jci.insight.121497. eCollection 2018 Sep 6.

3.

Cell-type specific potent Wnt signaling blockade by bispecific antibody.

Lee NK, Zhang Y, Su Y, Bidlingmaier S, Sherbenou DW, Ha KD, Liu B.

Sci Rep. 2018 Jan 15;8(1):766. doi: 10.1038/s41598-017-17539-z.

4.
5.

Modular Construction of Large Non-Immune Human Antibody Phage-Display Libraries from Variable Heavy and Light Chain Gene Cassettes.

Lee NK, Bidlingmaier S, Su Y, Liu B.

Methods Mol Biol. 2018;1701:61-82. doi: 10.1007/978-1-4939-7447-4_4.

PMID:
29116500
6.

Identification of Novel Macropinocytosing Human Antibodies by Phage Display and High-Content Analysis.

Ha KD, Bidlingmaier SM, Su Y, Lee NK, Liu B.

Methods Enzymol. 2017;585:91-110. doi: 10.1016/bs.mie.2016.10.004. Epub 2016 Dec 1.

PMID:
28109445
7.

Macropinocytosis Exploitation by Cancers and Cancer Therapeutics.

Ha KD, Bidlingmaier SM, Liu B.

Front Physiol. 2016 Sep 12;7:381. doi: 10.3389/fphys.2016.00381. eCollection 2016. Review.

8.

Proteome-wide Identification of Novel Ceramide-binding Proteins by Yeast Surface cDNA Display and Deep Sequencing.

Bidlingmaier S, Ha K, Lee NK, Su Y, Liu B.

Mol Cell Proteomics. 2016 Apr;15(4):1232-45. doi: 10.1074/mcp.M115.055954. Epub 2016 Jan 4.

9.

Utilizing Yeast Surface Human Proteome Display Libraries to Identify Small Molecule-Protein Interactions.

Bidlingmaier S, Liu B.

Methods Mol Biol. 2015;1319:203-14. doi: 10.1007/978-1-4939-2748-7_11.

10.

Identification of Posttranslational Modification-Dependent Protein Interactions Using Yeast Surface Displayed Human Proteome Libraries.

Bidlingmaier S, Liu B.

Methods Mol Biol. 2015;1319:193-202. doi: 10.1007/978-1-4939-2748-7_10. Review.

11.
12.

Combining Phage and Yeast Cell Surface Antibody Display to Identify Novel Cell Type-Selective Internalizing Human Monoclonal Antibodies.

Bidlingmaier S, Su Y, Liu B.

Methods Mol Biol. 2015;1319:51-63. doi: 10.1007/978-1-4939-2748-7_3.

13.

High-content analysis of antibody phage-display library selection outputs identifies tumor selective macropinocytosis-dependent rapidly internalizing antibodies.

Ha KD, Bidlingmaier SM, Zhang Y, Su Y, Liu B.

Mol Cell Proteomics. 2014 Dec;13(12):3320-31. doi: 10.1074/mcp.M114.039768. Epub 2014 Aug 22.

14.

Identification of protein/target molecule interactions using yeast surface-displayed cDNA libraries.

Bidlingmaier S, Liu B.

Methods Mol Biol. 2011;729:211-23. doi: 10.1007/978-1-61779-065-2_14.

15.

Construction of yeast surface-displayed cDNA libraries.

Bidlingmaier S, Liu B.

Methods Mol Biol. 2011;729:199-210. doi: 10.1007/978-1-61779-065-2_13.

16.

Comprehensive analysis of yeast surface displayed cDNA library selection outputs by exon microarray to identify novel protein-ligand interactions.

Bidlingmaier S, Wang Y, Liu Y, Zhang N, Liu B.

Mol Cell Proteomics. 2011 Mar;10(3):M110.005116. doi: 10.1074/mcp.M110.005116. Epub 2010 Dec 2.

17.

Identification of internalizing human single-chain antibodies targeting brain tumor sphere cells.

Zhu X, Bidlingmaier S, Hashizume R, James CD, Berger MS, Liu B.

Mol Cancer Ther. 2010 Jul;9(7):2131-41. doi: 10.1158/1535-7163.MCT-09-1059. Epub 2010 Jun 29.

18.

Identification of MCAM/CD146 as the target antigen of a human monoclonal antibody that recognizes both epithelioid and sarcomatoid types of mesothelioma.

Bidlingmaier S, He J, Wang Y, An F, Feng J, Barbone D, Gao D, Franc B, Broaddus VC, Liu B.

Cancer Res. 2009 Feb 15;69(4):1570-7. doi: 10.1158/0008-5472.CAN-08-1363. Epub 2009 Feb 3.

19.

The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells.

Bidlingmaier S, Zhu X, Liu B.

J Mol Med (Berl). 2008 Sep;86(9):1025-32. doi: 10.1007/s00109-008-0357-8. Epub 2008 Jun 6. Review.

20.

Interrogating yeast surface-displayed human proteome to identify small molecule-binding proteins.

Bidlingmaier S, Liu B.

Mol Cell Proteomics. 2007 Nov;6(11):2012-20. Epub 2007 Jul 28.

22.
23.

Carbohydrate analysis prepares to enter the "Omics" era.

Bidlingmaier S, Snyder M.

Chem Biol. 2002 Apr;9(4):400-1.

24.
25.

Global analysis of protein activities using proteome chips.

Zhu H, Bilgin M, Bangham R, Hall D, Casamayor A, Bertone P, Lan N, Jansen R, Bidlingmaier S, Houfek T, Mitchell T, Miller P, Dean RA, Gerstein M, Snyder M.

Science. 2001 Sep 14;293(5537):2101-5. Epub 2001 Jul 26.

26.

The Cbk1p pathway is important for polarized cell growth and cell separation in Saccharomyces cerevisiae.

Bidlingmaier S, Weiss EL, Seidel C, Drubin DG, Snyder M.

Mol Cell Biol. 2001 Apr;21(7):2449-62.

27.

Sustained correction of bleeding disorder in hemophilia B mice by gene therapy.

Wang L, Takabe K, Bidlingmaier SM, Ill CR, Verma IM.

Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3906-10.

28.
29.

Optimization of the human factor VIII complementary DNA expression plasmid for gene therapy of hemophilia A.

Ill CR, Yang CQ, Bidlingmaier SM, Gonzales JN, Burns DS, Bartholomew RM, Scuderi P.

Blood Coagul Fibrinolysis. 1997 Dec;8 Suppl 2:S23-30.

PMID:
9607110

Supplemental Content

Loading ...
Support Center